Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

RSLS ReShape Lifesciences Inc

0,1758

0,0008 (0,46%)

Nach Börsenschluss

Zuletzt aktualisiert: 23:24:10

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more ReShape Lifesciences Charts.

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more ReShape Lifesciences Charts.

News ReShape Lifesciences Inc

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Montag 1 April 2024 (1 Monat vor) • GlobeNewswire Inc.

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
Donnerstag 28 März 2024 (1 Monat vor) • GlobeNewswire Inc.

ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
Montag 4 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
Donnerstag 22 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
Mittwoch 24 Januar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 18 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 17 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Freitag 5 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
Mittwoch 20 Dezember 2023 (5 Monate vor) • GlobeNewswire Inc.

ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
Dienstag 12 Dezember 2023 (5 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 29 November 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere ReShape Lifesciences Inc News-Artikel

Financial Select Sector

BNP Paribas (QX)

Deutsche Telekom

Euro vs Sterling

Health Care Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen